The Targeted Pulse: A Review of Last Month’s FDA Prominent Actions and Key Data Updates Advancing Treatment Across ...
David Sallman, MD, discusses recent breakthroughs in the field of myelodysplastic syndromes (MDS). Specifically, investigators have gained a better understanding of MDS in order to design more effective clinical trials. Sallman highlights developments in …